Concise review: breast cancer stems cells and their role in metastases.
Autor: | Kamalabadi Farahani M; Department of Medical Laboratory Sciences, School of Paramedical., Farjadmehr M; Student Research Committee., Atashi A; Department of Tissue Engineering, School of Medicine, Shahroud University of Medical Sciences., Momeni A; Department of hematology and Oncology, School of Medicine., Behzadifard M; Department of Laboratory Sciences, School of Allied Medical Sciences, Dezful University of Medical Sciences, Dezful, Iran. |
---|---|
Jazyk: | angličtina |
Zdroj: | Annals of medicine and surgery (2012) [Ann Med Surg (Lond)] 2024 Jul 23; Vol. 86 (9), pp. 5266-5275. Date of Electronic Publication: 2024 Jul 23 (Print Publication: 2024). |
DOI: | 10.1097/MS9.0000000000002270 |
Abstrakt: | Background: Breast cancer stem cells (BCSCs) have been suggested to be responsible for the development of Breast cancer (BC). The aim of this study was to evaluate BCSCs and the target organs microenvironment immunophenotyping markers in common BC metastases, and therapeutic targets regarding to the mentioned criteria. Material and Methods: This narrative review involved searching international databases; PubMed, Google Scholar using predetermined keywords including breast cancer, breast cancer stem cells, breast cancer metastases, immunophenotyping, immunohistochemistry and metastases. The search results were assessed based on the title, abstract, and full text of the articles, and relevant findings were included in the review. Results: BCSCs express high amounts of aldehyde dehydrogenase 1 (ALDH1), Ganglioside 2 (GD2), CD44 and CD133 but are negative for CD24 marker. CXCR4 and OPN have high expression in the cells and may contribute in BC metastasis to the bone. Nestin, CK5, prominin-1 (CD133) markers in BCSCs have been reported to correlate with brain metastasis. High expression of CD44 in BCSCs and CXCL12 expression in the liver microenvironment may contribute to BC metastasis to the liver. Aberrantly expressed vascular cell adhesion molecule-1 (VCAM-1) that binds to collagen and elastin fibers on pulmonary parenchyma, and CXCR4 of BCSCs and CXCL12 in lung microenvironment may promote the cells homing and metastasis to lung. Conclusion: As in various types of BC metastases different markers that expressed by the cells and target organ microenvironment are responsible, BCSCs immunophenotyping can be used as target markers to predict the disease prognosis and treatment. Competing Interests: The authors declare no conflict of interest.Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article. (Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc.) |
Databáze: | MEDLINE |
Externí odkaz: |